The company said net sales for Q3 2024 were $3,192 million, up 4% from $3,058 million a year earlier, and organic sales rose 3%. It said organic growth reflected a 5% increase in volume partly offset by a 2% decrease in price.

1. 01

   The company said net sales for Q3 2024 were $3,192 million, up 4% from $3,058 million a year earlier, and organic sales rose 3%. It said organic growth reflected a 5% increase in volume partly offset by a 2% decrease in price.

2. 02

   DuPont said GAAP income from continuing operations for Q3 was $480 million ($291 million a year earlier), operating EBITDA was $857 million ($775 million a year earlier), and operating EBITDA margin was 26.8%.

3. 03

   The company said cash provided by operating activities from continuing operations for Q3 was $737 million, capital expenditures were $109 million, and transaction cost payments for the separations were $12 million, leaving transaction-adjusted free cash flow at $640 million.

4. 04

   DuPont raised its full-year outlook, now projecting operating EBITDA of about $3,125 million (prior outlook $3,060 million to $3,110 million) and adjusted EPS of about $3.90 (prior outlook $3.70 to $3.80).

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the opening part of the filing body and confirmed exhibits, within a length limit. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.